Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions
NCT04881006
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Dapagliflozin 10 mg tablets
DRUG:
Farxiga® 10 mg tablets
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.